These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1822347)

  • 1. Procainamide therapy, physical performance and energy expenditure in the Schwartz-Jampel syndrome.
    Spaans F; Wagenmakers A; Saris W; Reekers A; Theunissen P; Cremers H
    Neuromuscul Disord; 1991; 1(5):371-4. PubMed ID: 1822347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schwartz-Jampel syndrome: II. Na+ channel defect causes myotonia.
    Lehmann-Horn F; Iaizzo PA; Franke C; Hatt H; Spaans F
    Muscle Nerve; 1990 Jun; 13(6):528-35. PubMed ID: 2164152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
    Vargel I; Canter HI; Topaloglu H; Erk Y
    J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of myotonia with carbamazepine in three cases with the Schwartz-Jampel syndrome.
    Topaloğlu H; Serdaroğlu A; Okan M; Gücüyener K; Topçu M
    Neuropediatrics; 1993 Aug; 24(4):232-4. PubMed ID: 8232784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schwartz-Jampel syndrome: surgical management of the myotonia-induced blepharospasm and acquired ptosis after failure with botulinum toxin A injections.
    Morrison DA; Mellington FB; Hamada S; Moore AT
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):57-9. PubMed ID: 16418670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwartz-Jampel syndrome: report of one case.
    Yang MT; Yang CC; Chu LW; Lee WT; Young C; Wang PJ
    Acta Paediatr Taiwan; 2002; 43(4):220-3. PubMed ID: 12238912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single motor unit activity pattern in patients with Schwartz-Jampel syndrome.
    Christova LG; Alexandrov AS; Ishpekova BA
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):252-3. PubMed ID: 10071117
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and genetic features of Schwartz-Jampel syndrome in a Chinese child: case report and literature review].
    Dai L; Fang F; Huang Y; Cheng H; Ren C
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):855-9. PubMed ID: 26758326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondrodystrophic myotonia (Schwartz-Jampel syndrome): report of a new case and follow-up of patients initially reported in 1969.
    Edwards WC; Root AW
    Am J Med Genet; 1982 Sep; 13(1):51-6. PubMed ID: 7137221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbicularis myectomy with levator advancement in Schwartz-Jampel syndrome.
    Lucci LM; Yen MT; Anderson RL; Hwang IP; Black RE
    Am J Ophthalmol; 2001 Nov; 132(5):799-801. PubMed ID: 11704053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondrodystrophic myotonia (Schwartz-Jampel syndrome) in South African children.
    Moodley M; Moosa A
    Neuropediatrics; 1990 Nov; 21(4):206-10. PubMed ID: 2290482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-pathogenetic findings and management of chondrodystrophic myotonia (Schwartz-Jampel syndrome): a case report.
    Ho NC; Sandusky S; Madike V; Francomano CA; Dalakas MC
    BMC Neurol; 2003 Jul; 3():3. PubMed ID: 12839625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A injections for the treatment of Schwartz-Jampel syndrome: a case series.
    Aburahma SK; Al-Khateeb T; Alrefai A; Amarin Z
    J Child Neurol; 2009 Jan; 24(1):5-8. PubMed ID: 19168812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schwartz Jampel syndrome in children.
    Arya R; Sharma S; Gupta N; Kumar S; Kabra M; Gulati S
    J Clin Neurosci; 2013 Feb; 20(2):313-7. PubMed ID: 23219824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schwartz-Jampel syndrome with dominant inheritance.
    Pascuzzi RM; Gratianne R; Azzarelli B; Kincaid JC
    Muscle Nerve; 1990 Dec; 13(12):1152-63. PubMed ID: 2266988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schwartz-Jampel syndrome(chondrodystrophic myotonia)].
    Hemmi S; Sunada Y
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):38-40. PubMed ID: 11057135
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of muscle studies in the early diagnosis of Schwartz-Jampel syndrome].
    Vanlieferighen P; Francannet C; Dechelotte P; Malpuech G; de Laguillaumie B; Storme B
    J Genet Hum; 1987 Aug; 35(4):243-9. PubMed ID: 3655749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schwartz Jampel syndrome responding positively to carbamazepine therapy: a case report and a novel mutation.
    Gürbüz G; Albayrak HM
    Turk J Pediatr; 2019; 61(6):967-970. PubMed ID: 32134596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Blepharospasm in Schwartz-Jampel Syndrome: Botulinum Toxin A Injection or Surgery.
    Kashkouli MB; Shahrzad S; Jazayeri AA; Abtahi MB
    Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S47-S49. PubMed ID: 26020714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A in the treatment of facial myotonia in Schwartz-Jampel syndrome.
    Bandeira ID; Jagersbacher JG; Barretto TL; Santos CV; Lucena R
    Muscle Nerve; 2017 Aug; 56(2):E10-E11. PubMed ID: 28187499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.